ATP sensor helps to monitor disease severity


Friday, 04 March, 2022

ATP sensor helps to monitor disease severity

Japanese scientists have designed a prototype biosensor that detects levels of adenosine triphosphate (ATP) and lactates in a patient’s blood, enabling rapid assessment of the severity of some medical conditions. Their study has been published in the journal Biosensors and Bioelectronics.

ATP is a molecule found in every living cell that stores and carries energy. In red blood cells, ATP is produced by a biochemical pathway called the Embden–Meyerhof pathway. Severe illnesses such as multiple organ failure, sepsis and influenza reduce the amounts of ATP produced by red blood cells; as such, the severity of these illnesses could be gauged by monitoring the amounts of ATP and lactates in a patient’s blood.

“In 2013, our co-authors at Tokushima University proposed the ATP-lactate energy risk score (A-LES) for measuring ATP and lactate blood levels to assess acute influenza severity in patients,” said Hokkaido University’s Akihiko Ishida. “However, current methods to measure these levels and other approaches for measuring disease severity can be cumbersome, lengthy or not sensitive enough. We wanted to develop a rapid, sensitive test to help doctors better triage their patients.”

Ishida and colleagues at Hokkaido University and Tokushima University developed a biosensor that can detect levels of ATP and lactate in blood with great high sensitivity in a straightforward process that takes as little as five minutes.

Chemicals are added to a blood sample to extract ATP from red blood cells. Enzymes and substrates are then added to convert ATP and lactate to the same product that can be detected by specially modified electrodes on a sensor chip. The intensity of the current generated at the electrodes depends on the amount of by-product present in the sample.

The team conducted parallel tests and found that other components present in blood, such as ascorbic acid, pyruvic acid, adenosine diphosphate (ADP), urate and potassium ions, don’t interfere with the ability of the electrodes to accurately detect ATP and lactate. They also compared their sensor with those currently available and found it allowed for the relatively simple and rapid measurement of the two molecules.

“We hope our sensor will enable disease severity monitoring and serve as a tool for diagnosing and treating patients admitted to intensive care units,” Ishida said.

The researchers next aim to simplify the measurement process even further by integrating an ATP extraction method into the chip itself. They also plan to make their sensor system even more compact.

Image caption: The prototype of the ATP and lactate sensor developed for the study. Image credit: Akihiko Ishida.

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Researchers rediscover 'lost' coral and wildflower species

Researchers have discovered species of coral and wildflower that had been hidden for decades,...

CRC to tackle antimicrobial resistance threat to Australia

The Australian Government has announced $34.5m for the Cooperative Research Centre for Solving...

Pfizer to acquire ResApp, developer of smartphone COVID test

ResApp Health has developed a novel cough audio-based COVID-19 screening test that only requires...


  • All content Copyright © 2022 Westwick-Farrow Pty Ltd